MIAMI, Feb. 26, 2009 (GLOBE NEWSWIRE) -- Noven Pharmaceuticals, Inc. (Nasdaq:NOVN) today announced its 2008 earnings release date.
On March 5th, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter and year ended December 31, 2008. At 11:00 a.m. ET the same day, a conference call with management is scheduled to be webcast live at www.noven.com, and thereafter a rebroadcast will be available at the same site for at least two weeks. A taped replay of the call will be available beginning March 5 through March 8 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering the access code 286 and conference ID number 313659.
About Noven
Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven's business and operations are focused in three principal areas -- transdermal drug delivery, the Novogyne joint venture, and Noven Therapeutics, Noven's specialty pharmaceutical unit. For more information about Noven Pharmaceuticals, visit www.noven.com.
The Noven Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5938